Catalyst Wire Dossier Catalyst Wire Dossier

NGP 555

· NeuroGenetic Pharmaceuticals Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NGP 555, covering 2016-01-13 to 2017-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose) [Phase 1]

See pricing